Diabetologia - Up front: May 2020

The May 2020 issue is available at SpringerLink (this opens in a new tab).

Diabetic neuropathy: what does the future hold? (this opens in a new tab) Brian C. Callaghan, Gary Gallagher, Vera Fridman, Eva L. Feldman.

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study (this opens in a new tab). Marion M. Mafham, Louise J. Bowman, Richard J. Haynes, Jane M. Armitage.

Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology. (this opens in a new tab) Josephine Mollon, Joanne E. Curran, Samuel R. Mathias, Emma E. M. Knowles, Phoebe Carlisle, Peter T. Fox, Rene L. Olvera, Harald H. H. Göring, Amanda Rodrigue, Laura Almasy, Ravi Duggirala, John Blangero, David C. Glahn.

Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability. (this opens in a new tab) Jing Zhang, Longmin Chen, Faxi Wang, Yuan Zou, Jingyi Li, Jiahui Luo, Faheem Khan, Fei Sun, Yang Li, Jing Liu, Zhishui Chen, Shu Zhang, Fei Xiong, Qilin Yu, Jinxiu Li, Kun Huang, Bao-Ling Adam, Zhiguang Zhou, Decio L. Eizirik, Ping Yang, Cong-Yi Wang.

Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study. (this opens in a new tab) Amra Jujić, Naeimeh Atabaki-Pasdar, Peter M. Nilsson, Peter Almgren, Liisa Hakaste, Tiinamaija Tuomi, Lisa M. Berglund, Paul W. Franks, Jens J. Holst, Rashmi B. Prasad, Signe S. Torekov, Susana Ravassa, Javier Díez, Margaretha Persson, Olle Melander, Maria F. Gomez, Leif Groop, Emma Ahlqvist, Martin Magnusson.